Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Living without eosinophils: evidence from mouse and man
David J. Jackson, Ian Pavord
European Respiratory Journal (2022) Vol. 61, Iss. 1, pp. 2201217-2201217
Open Access | Times Cited: 22

Showing 22 citing articles:

Type 2 inflammation and biological therapies in asthma: Targeted medicine taking flight
Imran Howell, Aleksandra Howell, Ian Pavord
The Journal of Experimental Medicine (2023) Vol. 220, Iss. 7
Open Access | Times Cited: 28
Spatial adaptation of eosinophils and their emerging roles in homeostasis, infection and disease
Isabelle C. Arnold, Ariel Munitz
Nature reviews. Immunology (2024) Vol. 24, Iss. 12, pp. 858-877
Closed Access | Times Cited: 8
Eosinophils—from cradle to grave
Miloš Jeseňák, Zuzana Diamant, Dagmar Simon, et al.
Allergy (2023) Vol. 78, Iss. 12, pp. 3077-3102
Open Access | Times Cited: 18
Targeting the IL‐5 pathway in eosinophilic asthma: A comparison of anti‐IL‐5 versus anti‐IL‐5 receptor agents
David J. Jackson, Michael E. Wechsler, Guy Brusselle, et al.
Allergy (2024) Vol. 79, Iss. 11, pp. 2943-2952
Open Access | Times Cited: 7
Clonorchis sinensis infection amplifies hepatocellular carcinoma stemness, predicting unfavorable prognosis
Qiumei Lin, Zeli Tang, Yuling Qin, et al.
PLoS neglected tropical diseases (2024) Vol. 18, Iss. 1, pp. e0011906-e0011906
Open Access | Times Cited: 6
Mepolizumab depletes inflammatory but preserves homeostatic eosinophils in severe asthma
Michael Fricker, John Harrington, Sarah A. Hiles, et al.
Allergy (2024) Vol. 79, Iss. 11, pp. 3118-3128
Open Access | Times Cited: 5
A Scoping Review of Eosinophilic Pneumonia and Antidepressants: An Association Not to Be Overlooked
Jöerg M. Steiner, Leonie Steuernagel, Fotios Drakopanagiotakis, et al.
Diseases (2025) Vol. 13, Iss. 1, pp. 13-13
Open Access
Allergy-unrelated eosinophil activation in the peripheral blood of children with neurodevelopmental disorders
Wenjing Ji, Muhan Li, Chenlu Yang, et al.
Brain Behavior & Immunity - Health (2025), pp. 100960-100960
Open Access
What Every Clinician Should Know About Inflammation in COPD
Michael E. Wechsler, J. Michael Wells
ERJ Open Research (2024) Vol. 10, Iss. 5, pp. 00177-2024
Open Access | Times Cited: 3
Therapeutic relevance of eosinophilic inflammation and airway viral interactions in severe asthma
Hitasha Rupani, William W. Busse, Peter Howarth, et al.
Allergy (2024) Vol. 79, Iss. 10, pp. 2589-2604
Open Access | Times Cited: 3
Real-World Safety Profile of Biologic Drugs for Severe Uncontrolled Asthma: A Descriptive Analysis from the Spanish Pharmacovigilance Database
Carlos Boada-Fernández-del-Campo, Marcelino García-Sánchez-Colomer, Eduardo Fernández-Quintana, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 14, pp. 4192-4192
Open Access | Times Cited: 2
Cell type‐specific molecular mechanisms and implications of necroptosis in inflammatory respiratory diseases
Ying Guo, Jin Zhou, Yaqi Wang, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 52-70
Closed Access | Times Cited: 5
Ally, adversary, or arbitrator? The context-dependent role of eosinophils in vaccination for respiratory viruses and subsequent breakthrough infections
Lauren A. Chang, Michael Schotsaert
Journal of Leukocyte Biology (2024)
Open Access | Times Cited: 1
MELTEMI and COLUMBA: 5-Year Comparative Safety Analysis of Benralizumab and Mepolizumab
Arnaud Bourdin, Geoffrey Chupp, David J Jackson, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 8, pp. 2074-2083.e4
Open Access | Times Cited: 1
Domestic Parasitic Infections in Patients with Asthma and Eosinophilia in Germany – Three Cases with Learnings in the Era of Anti- IL5 Treatments
Michaela Barnikel, Ulrich Grabmaier, Pontus Mertsch, et al.
Journal of Asthma and Allergy (2023) Vol. Volume 16, pp. 1229-1232
Open Access | Times Cited: 2
Research progress of serum eosinophil in chronic obstructive pulmonary disease and asthma
Congli Wu
Open Life Sciences (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Eosinophilia and the Hypereosinophilic Syndrome: Clinical, Molecular and Translational Aspects
Clayton Jackson, Akshaya K. Sasankh, Nitya Krishna Arumugam, et al.
Elsevier eBooks (2024), pp. 323-357
Closed Access
Considerations on the Evolutionary Biology and Functions of Eosinophils: What the ‘Haeckel’?
Steven J. Ackerman, Nicole I. Stacy
Journal of Leukocyte Biology (2024)
Closed Access
Eosinophils Play a Surprising Leading Role in Recurrent Urticaria in Horses
Katharina Birkmann, Fadi Jebbawi, Nina Waldern, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 562-562
Open Access
Transforming Care in SEA: Evidence and Considerations for Evolution of the Current Treatment Paradigm
Bjørn Hanger
EMJ Respiratory (2024), pp. 41-50
Open Access
Eosinophils – Role in Immunity
Paige Lacy
Elsevier eBooks (2024)
Closed Access
Vectorized Human Antibody-Mediated Anti-Eosinophil Gene Therapy
Maria Gioulvanidou, Selenay S. Sarklioglu, Xinlei Chen, et al.
Human Gene Therapy (2024)
Closed Access
Page 1

Scroll to top